Markets:

Overview

News

Currencies

International

Treasuries

Penumbra, Inc. Common Stock (NY:PEN)

341.02 -0.99 (-0.29%)

Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Penumbra, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

The $3.2 Trillion ‘Wall of Capital’: Private Equity Unleashes a Global M&A Renaissance in 2026

February 06, 2026

As of February 6, 2026, the global financial landscape is being reshaped by an unprecedented "wall of capital." After nearly two years of stagnation caused by valuation gaps and high borrowing costs,...

Via MarketMinute

The Great Rebound: US M&A Activity Surges 111% as Megadeals Return to Wall Street

February 06, 2026

The long-awaited "deal drought" has officially broken. As of early February 2026, the American financial landscape is being reshaped by a massive resurgence in corporate deal-making, punctuated by a...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Penumbra Shares Soar Pre-Market — What Is The Boston Scientific Agreement? ↗

January 15, 2026

Via Stocktwits

The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition

February 05, 2026

In a move that has sent shockwaves through the medical technology sector, Boston Scientific (NYSE:BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra (NYSE:PEN) for...

Via MarketMinute

Topics Supply Chain

The Return of the Giants: Private Equity Mega-Deals Surge in Early 2026

February 05, 2026

The "Great Hesitation" in global finance has officially come to an end. In the opening weeks of 2026, the private equity landscape has undergone a dramatic transformation, shifting from two years of...

Via MarketMinute

Topics Artificial Intelligence Economy Initial Public Offering

Navigating the MedTech Correction: A Deep-Dive into Boston Scientific (NYSE: BSX)

February 05, 2026

February 5, 2026 The medical technology landscape experienced a seismic shift this week as one of its long-standing titans, Boston Scientific (NYSE: BSX), faced a "valuation reset" that has left...

Via Finterra

Topics Product Recall World Trade

Why Boston Scientific Stock Plummeted Today ↗

February 04, 2026

I'll be keeping a close eye on Boston Scientific stock following the market's peculiar reaction to its solid earnings report.

Via The Motley Fool

Halper Sadeh LLC Reminds Shareholders of RAPT, PEN, CVGW, FONR of the Firm’s Investigations

February 02, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights.

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq – RAPT), Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), FONAR Corporation (Nasdaq - FONR)

February 02, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Boston Scientific’s $14.5 Billion Stroke of Genius: Consolidation Heats Up in the Medtech Arms Race

February 02, 2026

In a move that has sent shockwaves through the healthcare sector, Boston Scientific (NYSE:BSX) has announced a definitive agreement to acquire Penumbra (NYSE:PEN) for approximately $14.5 billion. The...

Via MarketMinute

Topics Artificial Intelligence

Halper Sadeh LLC Encourages NATH, PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights

January 29, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

Boston Scientific to Acquire Penumbra for $14.5 Billion in Massive MedTech Consolidation

January 28, 2026

MARLBOROUGH, Mass. — In a move that has sent shockwaves through the medical technology landscape, Boston Scientific (NYSE: BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra...

Via MarketMinute

The $14.5 Billion Clot-Bust: Boston Scientific’s Bold Bet on Penumbra Signals a New Era of Medtech Giants

January 27, 2026

In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced on January 15, 2026, its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN)...

Via MarketMinute

Halper Sadeh LLC Encourages PEN and RAPT Shareholders to Contact the Firm to Discuss Their Rights

January 27, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

S&P 500 Hits Record Highs as Tech Earnings Ignite Market Rally

January 27, 2026

The U.S. stock market reached a historic milestone on January 27, 2026, as the S&P 500 (NYSEARCA:SPY) climbed to a fresh all-time high of 6,980.75, tantalizingly close to the psychologically...

Via MarketMinute

Topics Artificial Intelligence Economy Government

The Great Consolidation: US M&A Values Double as AI and Bio-Pharma Spark $2 Trillion Surge

January 26, 2026

As of January 26, 2026, the American corporate landscape is undergoing its most radical transformation in a generation. Following a two-year period of high-interest-rate hibernation, the United States...

Via MarketMinute

Topics Artificial Intelligence Economy

The Great Mid-Cap Rotation: Fed Rate Cuts Spark a New Bull Run for the 'Forgotten' Middle Market

January 23, 2026

As the Federal Reserve transitions from its long-standing "higher-for-longer" stance to a deliberate cycle of monetary easing, the U.S. equity market is witnessing a profound shift in leadership. For...

Via MarketMinute

Topics Artificial Intelligence Economy Supply Chain

Halper Sadeh LLC Encourages PEN, FOLD, DBRG, FFIC Shareholders to Contact the Firm to Discuss Their Rights

January 22, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC Encourages PEN, EXAS, DBRG, FFIC Shareholders to Contact the Firm to Discuss Their Rights

January 21, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights.

From Halper Sadeh LLC

Via GlobeNewswire

3 Reasons to Sell PEN and 1 Stock to Buy Instead

January 20, 2026

The past six months have been a windfall for Penumbra’s shareholders. The company’s stock price has jumped 55.5%, setting a new 52-week high of $355.93 per share. This was partly thanks to its solid...

Via StockStory

Topics Supply Chain

January 20, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

3 High-Flying Stocks That Fall Short

January 18, 2026

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices,...

Via StockStory

Halper Sadeh LLC Encourages PEN, CVGW, AVO Shareholders to Contact the Firm to Discuss Their Rights

January 17, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

"Animal Spirits" Return: Morgan Stanley Signals M&A Renaissance as Healthcare and Industrials Lead Shifting Landscape

January 15, 2026

As 2026 begins, the global mergers and acquisitions (M&A) market is witnessing a profound "renaissance," driven by a confluence of stabilizing interest rates, record levels of corporate cash, and a...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

Why Penumbra (PEN) Stock Is Trading Up Today

January 15, 2026

Shares of medical device company Penumbra (NYSE:PEN) jumped 12.1% in the afternoon session after the company agreed to be acquired by Boston Scientific in a deal valued at approximately $14.5 billion.

Via StockStory

Topics Artificial Intelligence Supply Chain

Halper Sadeh LLC Encourages VTYX, PEN, CWAN Shareholders to Contact the Firm to Discuss Their Rights

January 15, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

The Thrombectomy Titan: Boston Scientific Shakes MedTech with $14.5 Billion Penumbra Acquisition

January 15, 2026

MARLBOROUGH, MA – In a move that has sent shockwaves through the medical device sector, Boston Scientific Corporation (NYSE:BSX) announced today, January 15, 2026, a definitive agreement to acquire...

Via MarketMinute

Topics Artificial Intelligence

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), Clearwater Analytics Holdings, Inc. (NYSE - CWAN)

January 15, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

These stocks are gapping in today's session ↗

January 15, 2026

Via Chartmill

PEN Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Penumbra, Inc. is Fair to Shareholders

January 15, 2026

From Halper Sadeh LLC

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Penumbra, Inc. Common Stock (NY:PEN)

All News about Penumbra, Inc. Common Stock

Starting at $3.75/week.

Subscribe Today